NEW YORK (Reuters Health) – Infliximab for inflammatory bowel disease (IBD) is not associated with an increased risk for serious infection, death, or malignancy, including lymphoma, according to…
NEW YORK (Reuters Health) – The antiarrhythmic dronedarone (Multag, Sanofi SA) should be used with caution, particularly in patients with cardiovascular risk factors, advise clinicians in a report…
NEW YORK (Reuters Health) – In a large population-based cohort from Italy, aspirin therapy for primary prevention of cardiovascular events was associated with a significantly increased risk of…
NEW YORK (Reuters Health) – Generally, the accuracy of antigen-based point-of-care tests for hepatitis B infection is high, but the sensitivity of antibody-based tests needs to be improved,…
NEW YORK (Reuters Health) – Intensive control of blood pressure does have a clinically significant positive or negative impact on depression or patient-reported health-related quality of life, according…
NEW YORK (Reuters Health) – Higher thyrotropin levels are associated with an increased risk of developing gestational diabetes, according to a report in the May 2012 Obstetrics &…
NEW YORK (Reuters Health) – Contrary to some study findings, statin therapy does not increase the risk of intracerebral hemorrhage (ICH) significantly, according to the results of a…
NEW YORK (Reuters Health) – Monthly intramuscular injection of a depot formulation of aripiprazole delays the time to impending relapse in stabilized adults with schizophrenia, and has a…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, intensive control of blood sugar reduces the risk of microalbuminuria and macroalbuminuria, but its impact on hard…
NEW YORK (Reuters Health) – For the millions of patients who come to the ED each year complaining of chest pain, an accelerated diagnostic protocol can accurately identify…